Clinical Trials for Mesothelioma Patients—Electronic Tool to Record Cancer Symptoms: Study Objectives

Read about the primary, secondary and tertiary objectives for a current clinical trial of electronic tool being conducted on patients with advanced cancer or malignant mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. This trial is currently only being conducted in Switzerland.

Primary Objectives:

• Determine the effect of an electronic tool for monitoring symptoms and syndromes associated with advanced cancer (E-MOSAIC) and a Longitudinal Monitoring Sheet (LoMoS) on global quality of life (G-QOL) of patients with advanced incurable cancer receiving palliative anticancer treatment.

Secondary Objectives:

• Determine if this tool affects communication between these patients and their treating physicians.

• Determine if this tool affects the symptoms and syndromes reported by these patients.

• Determine if this tool impacts symptom management performance.

Tertiary Objectives:

• Identify factors influencing changes in G-QOL.

• Determine how patients adapt to illness and burden of treatment.

• Describe patients' decision-making preference. Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health